glp-1 receptor agonist diarrhea management Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus Current Insights, Advantages and Challenges
Description
Association between obesity, high-sensitivity C-reactive protein 2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis
doi: 10.1056/NEJMoa2404881 34
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Mentlein R, Gallwitz B, Schmidt WE
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Another 17.7 percent regained the weight they lost or exceeded their initial weight
